<DOC>
	<DOCNO>NCT02792387</DOCNO>
	<brief_summary>The aim study explore association increase central venous pressure , Ejection Fraction renal dysfunction ( eGFR ) patient Cardio-Renal Syndromes type 1 2 . The pilot study set provide expect correlation coefficient sample size determination subsequent study .</brief_summary>
	<brief_title>The Role CVP Patients With Cardio-renal Syndromes</brief_title>
	<detailed_description>OBJECTIVES The aim study explore association increase central venous pressure ( CVP ) , Ejection Fraction ( EF ) renal dysfunction ( eGFR ) patient Cardio-Renal Syndromes type 1 2 . BACKGROUND The pathophysiology impair renal function cardiovascular disease multifactorial . Recent investigation suggest management patient base low-flow theory lead improve outcome . Relative importance right heart dysfunction ( manifest increase CVP ) evaluate . Precise understanding bidirectional pathway heart kidney influence necessary define optimal treatment strategy specific subtypes , therapy direct towards one organ system may beneficial unfavorable effect . METHODS The study non-experimental ( observational ) type , base retrospective chart review . The patient ' personal identifier conceal anonymized datasets use ( unique code give patient , keep secure control hospital staff ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<criteria>HF ( NYHA class I IV , preserve reduced EF ) reduce GFR ( CardioRenal Syndromes 1 2 ) Independent risk factor renal impairment ( e.g . diabetes , sepsis ) Primary nephropathy secondary nephropathy due disease HF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cardio-renal syndrome</keyword>
	<keyword>right heart dysfunction</keyword>
	<keyword>central venous pressure</keyword>
	<keyword>eGFR</keyword>
	<keyword>low-flow theory</keyword>
</DOC>